Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - PubMed (original) (raw)

Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI)

Muzeeb Syed et al. Toxicol In Vitro. 2016 Mar.

Abstract

Diclofenac is a widely prescribed NSAID, which by itself and its reactive metabolites (Phase-I and Phase-II) may be involved in serious idiosyncratic hepatotoxicity. Mitochondrial injury is one of the mechanisms of drug induced liver injury (DILI). In the present work, an investigation of the inhibitory effects of diclofenac (Dic) and its phase I [4-hydroxy diclofenac (4'-OH-Dic) and 5-hydroxy diclofenac (5-OH-dic)] and Phase-II [diclofenac acyl glucuronide (DicGluA) and diclofenac glutathione thioester (DicSG)] metabolites, on ATP synthesis in rat liver mitochondria was carried out. A mechanism based inhibition of ATP synthesis is exerted by diclofenac and its metabolites. Phase-I metabolite (4'-OH-Dic) and Phase-II metabolites (DicGluA and DicSG) showed potent inhibition (2-5 fold) of ATP synthesis, where as 5-OH-Dic, one of the Phase-I metabolite, was a less potent inhibitor as compared to Dic. The calculated kinetic constants of mechanism based inhibition of ATP synthesis by Dic showed maximal rate of inactivation (Kinact) of 2.64 ± 0.15 min(-1) and half maximal rate of inactivation (KI) of 7.69 ± 2.48 μM with Kinact/KI ratio of 0.343 min(-1) μM(-1). Co-incubation of mitochondria with Dic and reduced GSH exhibited a protective effect on Dic mediated inhibition of ATP synthesis. Our data from this study strongly indicate that Dic as well as its metabolites could be involved in the hepato-toxic action through inhibition of ATP synthesis.

Keywords: ATP; Diclofenac; Drug induced liver injury; Metabolites; Oxidative phosphorylation; Rat liver mitochondria.

PubMed Disclaimer

Cited by

Continous, non-invasive monitoring of oxygen consumption in a parallelized microfluidic in vitro system provides novel insight into the response to nutrients and drugs of primary human hepatocytes.
Busche M, Rabl D, Fischer J, Schmees C, Mayr T, Gebhardt R, Stelzle M. Busche M, et al. EXCLI J. 2022 Jan 7;21:144-161. doi: 10.17179/excli2021-4351. eCollection 2022. EXCLI J. 2022. PMID: 35145369 Free PMC article.
Progression of Repair and Injury in Human Liver Slices.
Vickers AEM, Ulyanov AV, Fisher RL. Vickers AEM, et al. Int J Mol Sci. 2018 Dec 19;19(12):4130. doi: 10.3390/ijms19124130. Int J Mol Sci. 2018. PMID: 30572671 Free PMC article.
Lysophosphatidylcholine induces adenosine release from macrophages via TRPM7-mediated mitochondrial activation.
Youssef AM, Song DK. Youssef AM, et al. Purinergic Signal. 2022 Sep;18(3):317-343. doi: 10.1007/s11302-022-09878-y. Epub 2022 Jul 2. Purinergic Signal. 2022. PMID: 35779163 Free PMC article. Retracted.
An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac.
Selvaraj S, Oh JH, Borlak J. Selvaraj S, et al. Arch Toxicol. 2020 Aug;94(8):2733-2748. doi: 10.1007/s00204-020-02767-6. Epub 2020 May 5. Arch Toxicol. 2020. PMID: 32372211 Free PMC article.
Elevated cAMP Protects against Diclofenac-Induced Toxicity in Primary Rat Hepatocytes: A Protective Effect Mediated by the Exchange Protein Directly Activated by cAMP/cAMP-Regulated Guanine Nucleotide Exchange Factors.
Aguilar Mora FA, Musheshe N, Oun A, Buist-Homan M, Lezoualc'h F, Cheng X, Schmidt M, Moshage H. Aguilar Mora FA, et al. Mol Pharmacol. 2021 Apr;99(4):294-307. doi: 10.1124/molpharm.120.000217. Epub 2021 Feb 11. Mol Pharmacol. 2021. PMID: 33574047 Free PMC article.

Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - PubMed (original) (raw)